Effect of Rasagiline in Patients With Parkinson's Disease

Study Title
ParFemale, Maleel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease
Teva Identifier
TVP-1012/PM106
ClinicalTrials.gov Identifier
NCT01723228
Study Status
Completed
Trial Condition(s)
Parkinson's Disease
Interventions
Drug: Rasagiline | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
45 Years to 80 Years
Trial Duration
11/01/2012 - 01/01/2015
Phase
Phase 4

Study Type

Interventional